Internet and Psychiatry
  • Home
    • Editorials
    • Research news
    • Research papers
    • Interviews with eminent psychiatrists
    • Ten years ago
    • Fifteen years ago
  • Topics
    • Alcohol and Drug Abuse
    • Anxiety Disorders
    • Biomedical Science
    • Compulsive gambling
    • Disaster Medicine
    • Education
    • General Medicine
      • Acupuncture
      • Physical medicine and Rehabilitation
    • Human Rights
    • Interviews with eminent psychiatrists
    • Mood Disorders
      • Bipolar Disorder
      • Depression
      • Seasonal Affective Disorder
    • Neurological Disorders
    • Other Psychiatric Disorders
    • Posttraumatic Stress Disorder
    • Sexual Behavior
  • Books
    • Comorbidity of Depression and Alcohol Use Disorders
    • “Immigration and Mental Health” chapter abstracts
    • “Internet and Suicide” chapter abstracts
    • “Neurobiology of PTSD” chapter abstracts
    • “Suicidal Behavior in Alcohol…” chapter abstracts
    • “Suicide in the Military” chapter abstracts
    • “Terror and Suicide” chapter abstracts
    • “War and Suicide” chapter abstracts
  • Editors
    • Leo Sher, M.D.
    • Alexander Vilens, M.S.
  • Guests
    • Distinguished Guests
    • Our Contributors
  • Reflections
    • Poetry
    • Quotes

Editorials

Catatonia: A much expanded diagnostic view

April 25, 2016

Kendall Bache, M.D., Kanwarjeet Brar, M.D., Steven Lippmann, M.D.

Catatonia has been a condition commonly associated with schizophrenia, but it exists in a number of other psychiatric disorders.  Diagnostic criteria for catatonia involves at least three of these twelve findings: catalepsy, waxy flexibility, posturing, mutism, negativism, mannerism, stereotypy, grimacing, stupor, agitation, echolalia, and/or echopraxia.  However, catatonia can also be a sign of medical or neurological conditions. An expanded understanding of potential etiologies speeds recognition, diagnosis, and treatment.    

Catatonia with a psychiatric etiology is usually recognized when encountering a patient with this clinical presentation.  Psychopathology associated with catatonia includes schizophrenia, bipolar disorder, other psychoses, depression, other mood or anxiety disorders, autism, and Gilles de la Tourette Syndrome.  Pharmacotherapy is the acute conventional treatment; benzodiazepines are often the drug of choice, antipsychotic medications and in some cases ECT can also be helpful.  Then, treat the primary psychopathology in a routine manner.

When evaluating a patient with catatonia that lacks psychiatric indicators, medical conditions should be considered.   Infectious etiologies can incorporate viral, bacterial, or parasitic encephalopathies leading to a catatonic state.  Potential metabolic aberrations include hyponatremia, homocystinuria, hypercalcemia, porphyria, and severe hepatic or renal dysfunction.  Endocrine abnormalities such as hypothyroidism, hyperthyroidism, hyperparathyroidism, and adrenal malignancies can also induce catatonia. It can even emerge with substance intoxications or withdrawal states.  The substances involved with catatonic presentations include alcohol, sedatives, opiates, stimulants, and hallucinogens.  Appropriate evaluation, imaging, and laboratory testing are mandated and followed by treating the specific underlying medical pathology. Symptomatic therapies, on a calmative basis, might be required in addition, if urgently indicated.

Neurological disorders also can present with catatonia and affect various areas of the brain. The basal ganglia, limbic system, frontal, temporal or parietal lobes, third ventricle, thalamus, globus pallidus, caudate, and/or anterior putamen can be the site of the pathology, due to epilepsy, contusion, atrophy, neoplasm, or space-occupying lesion.  After identifying the underlying disorder, instituting appropriate neurological intervention is indicated. Symptomatic sedation may be prescribed adjunctively, in an individualized manner if needed.

Catatonia although most often associated with psychiatric disorders can also be a sign of other underlying etiologies within general medicine or due to neuropathologies.  Physicians should always consider a variety of differential diagnoses when encountering a patient who exhibits catatonia.

Suggested Readings

1.    Diagnostic and Statistical Manual of Mental Disorders: DSM- V. (2013) Washington D.C.: American Psychiatric Association.
2.    Brown M, Freeman S. Clonazepam withdrawal-induced catatonia. Psychosomatics. 2009; 50(3):289-292.
3.    Niraj Ahuja. Organic Catatonia: A Review. Indian Journal of Psychiatry. 2000; 42(4):327-346.
4.    Sadock, V.A., Sadock, B. J., Ruiz, P.(2014). Kaplan and Sadock’s Synopsis of Psychiatry: Behavorial Sciences/Clinical Psychiatry; Philidelpia PA. :Wolters Kluwer.

Related Posts

Editorials /

The role of the h-index in academic medicine

Editorials /

A timeless commitment: Reflections on the Hippocratic Oath

Editorials /

Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  

‹ More than one-third of the adults in the U.S. report sleeping less than seven hours in a 24-hour period: A CDC study › Congratulations to Professor Masahito Fushimi!

Editorials

  • The role of the h-index in academic medicine
  • A timeless commitment: Reflections on the Hippocratic Oath
  • Abraham Flexner history: Celebrated medical educator – improved physician training, yet also left a not well-known legacy  
  • Suicide medical malpractice: A conceptual perspective

Research Papers

  • COVID-19 mortality in Europe and the ’Iron Curtain’ between East and West
  • Examination of depressive signs and symptoms among 803 University students in seven Universities and Colleges. Hungary, Romania, Serbia.
  • Examination of spirituality and the dimensions of spirituality among 803 students in seven different Universities. Hungary, Romania and Serbia.
  • Examination of depressive signs and symptoms among 932 students in eight different secondary schools in Hungary

Research News

  • Blood alcohol concentration and suicide mortality in Finland
  • Suicide risk in older adults: clinical responsibilities and medico-legal considerations
  • Conceptualizing a combat veteran’s suicide death through the stress-diathesis model
  • No evidence of a causal link between glucagon-like peptide-1 receptor agonists and suicidal behavior

Latest News

  • FDA launches real-time clinical trial initiative
  • The 2025 ScholarGPS rankings of leading scholars in suicidology
  • Mental health support for healthcare professionals
  • The 2024 ScholarGPS ranking of scholars in the field of suicidology

Interviews with eminent psychiatrists

  • 2026 Interview with Professor Zoltan Rihmer
  • 2026 Interview with Doctor María Dolores Braquehais Conesa
  • 2026 Interview with Professor Shih-Ku Lin
  • Interview with Professor Jess G. Fiedorowicz

Ten Years Ago

  • Suicide malpractice
  • Testosterone levels and future suicide attempts in women with bipolar disorder
  • Bipolar disorder, testosterone administration, and homicide
  • The cosyntropin stimulation test in military veterans with or without posttraumatic stress disorder

Back to Top

  • About
  • Contact
  • Privacy Policy
  • Terms and Conditions
Copyright © 2025 AVCalc LLC. All rights reserved worldwide.